
We see precision medicine as the future of cancer care.
Let’s make it happen, together. Our cutting-edge genomic profiling technology covers all cancer and sample types to accelerate precision cancer care. We work closely with you to solve your specific needs, with a relentless focus on quality and efficiency.
EXPERIENCE MATTERS.WE HAVE IT.
Services for Oncology Clinical Trials
-
- NGS services
- CDx + LDT strategy
- Project management
- Sample logistics and storage
- Data analysis and storage
- Customized QC/QA solutions
NGS Services for Precision Oncology
-
- Pan-cancer genetic test for solid tumors
- ctDNA liquid biopsy
- Over 30 clinical NGS testing products for different cancers
- Over 10 products under development
NGS-based CDx Kit for Diagnosis
-
- Essencare ™ EGFR/ALK/ROS1/BRAF/KRAS/HER2 mutant testing kit (reversible terminator technology)
NGS Services for Research
-
- DNA sequencing
- WGS, WES
- Targeted panel sequencing
- DNA methylation sequencing
- Customer-made library sequencing
- RNA sequencing
- Whole transcriptome sequencing
- Small RNA sequencing, including miRNA, siRNA and piRNA
- Circular RNA sequencing
- DNA sequencing

400,000+
SAMPLES
sequenced for cancer patients

500+
HOSPITALS
in which our products are used

30+
PRODUCTS
for solid tumors & blood cancers

1500+
CLINICAL PROJECTS
in translational research

250+
PUBLICATIONS
in the past 5 years
Certified to the highest international clinical lab standards




Genomic Testing
The most diverse range of cancer genomic testing available
Using comprehensive genomic insights, we help match cancer patients to optimal treatments, including targeted therapy and immunotherapy. Our pan-cancer panel analyzes 425 genes, while specific panels target individual cancer types. We partner with you to give you the insights you need to take action – from treatment decisions to new therapy development.
Research Services
A strong partner to drive research forward
Our company is built on a strong foundation of research, with deep scientific expertise and active R&D. We have 1500+ research projects with biopharma and research partners, providing high-quality genomic data to accelerate translational research. We offer full research services, including project design & management, next-generation sequencing, QC/QA and data analysis, tailored to your needs.


OUR TECHNOLOGY
Reliable and fast is possible
We are continuously evolving our sequencing technology as we gain new knowledge. This ensures an optimized workflow – from sample preparation, mutation calling and data mining to machine-learning and exclusive genomic databases – and a very high sequencing capacity. To date, we have sequenced 400,000+ samples, with high sensitivity and specificity and a turnaround time of just five business days.
LET’S ACCELERATE PRECISION CANCER CARE, TOGETHER.
Learn more about our products and services or contact us today to discuss how we can partner together.
Our News
January 25, 2021
Geneseeq and Collaborators to Present New Clinical Research Data during the 2020 IASLC World Conference on Lung Cancer in Singapore
TORONTO, January 25, 2021,10:00 ET - Geneseeq Technology Inc.…
May 13, 2019
New biomarkers to predict patients’ clinical outcomes to ICI therapy in lung cancer
New biomarkers to predict patients’ clinical outcomes to ICI therapy…
December 1, 2018
Geneseeq and Illumina to Develop Clinical Oncogene Kit
Geneseeq and Illumina to Develop Clinical Oncogene Kit Accelerate…